Parkinson's disease (PD) is the second most common neurodegenerative disease. The
development of PD is closely linked to genetic and environmental factors, with GBA1 …

Parkinson disease (PD) is a neurodegenerative disorder marked by the preferential
dysfunction and death of dopaminergic neurons in the substantia nigra. The onset and …

GenoTools, a Python package, streamlines population genetics research by integrating
ancestry estimation, quality control, and genome-wide association studies capabilities into …

Background Commercial genome‐wide genotyping arrays have historically neglected
coverage of genetic variation across populations. Objective We aimed to create a multi …

An exciting development in the field of neurodegeneration is the association between the
rare monogenic disorder Gaucher disease and the common complex disorder Parkinson …

Parkinson's disease (PD) is a global health challenge, yet historically studies of PD have
taken place predominantly in European populations. Recent genetics research conducted in …

Knowledge on the genetic basis of Parkinson's disease has grown tremendously since the
discovery of the first monogenic form, caused by a mutation in α-synuclein, and with the …

Research on neurodegenerative diseases has predominantly focused on high-income
countries in the Global North. This Series paper describes the state of biomarker evidence …

This scientific commentary refers to 'Relevance of genetic testing in the gene-targeted trial
era: the Rostock Parkinson's Disease Study'by Westenberger et al.(https://doi …

Background Identifying hereditary parkinsonism is valuable for diagnosis, genetic
counseling, patient prioritization in trials, and studying the disease for personalized …